Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients

NCT00238953 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Transplantation

Interventions

DRUG: Enteric-Coated Mycophenolate Sodium (EC-MPS)

Sponsor

Novartis